Shoulder Innovations (NYSE:SI) Major Shareholder Healthcare Holding B.V. Gilde Sells 681 Shares

Shoulder Innovations, Inc. (NYSE:SI) major shareholder Healthcare Holding B.V. Gilde sold 681 shares of Shoulder Innovations stock in a transaction on Monday, August 24th. The shares were sold at an average price of $22.62, for a total transaction of $15,404.22. Following the transaction, the insider owned 2,187,110 shares in the company, valued at $49,472,428.20. The trade was a 0.03% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Major shareholders that own more than 10% of a company’s shares are required to disclose their transactions with the SEC.

Healthcare Holding B.V. Gilde also recently made the following trade(s):

• On Friday, August 21st, Healthcare Holding B.V. Gilde sold 20,516 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.61, for a total value of $463,866.76.
• On Thursday, August 20th, Healthcare Holding B.V. Gilde sold 3,900 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.60, for a total value of $88,140.00.
• On Thursday, August 6th, Healthcare Holding B.V. Gilde sold 2,095 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.60, for a total value of $47,347.00.
• On Wednesday, August 5th, Healthcare Holding B.V. Gilde sold 7,338 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.64, for a total value of $166,132.32.
• On Tuesday, August 4th, Healthcare Holding B.V. Gilde sold 99,812 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.77, for a total value of $2,272,719.24.
• On Monday, August 3rd, Healthcare Holding B.V. Gilde sold 10,751 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.71, for a total value of $244,155.21.
• On Friday, July 31st, Healthcare Holding B.V. Gilde sold 20,034 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.73, for a total value of $455,372.82.
• On Thursday, July 30th, Healthcare Holding B.V. Gilde sold 28,245 shares of Shoulder Innovations stock. The shares were sold at an average price of $23.36, for a total transaction of $659,803.20.

Shoulder Innovations Trading Up 0.8%

NYSE SI opened at $22.24 on Tuesday. The stock has a market cap of $463.02 million and a P/E ratio of -11.58. The company’s fifty day simple moving average is $21.03 and its 200-day simple moving average is $16.60. The company has a current ratio of 10.71, a quick ratio of 8.92 and a debt-to-equity ratio of 0.12. Shoulder Innovations, Inc. has a 52 week low of $10.92 and a 52 week high of $24.59.

Shoulder Innovations (NYSE:SI) last released its quarterly earnings results on Thursday, August 6th. The company reported ($0.49) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.46) by ($0.03). The firm had revenue of $17.18 million for the quarter. Shoulder Innovations had a negative return on equity of 23.61% and a negative net margin of 58.33%. Equities research analysts predict that Shoulder Innovations, Inc. will post -1.9 EPS for the current fiscal year.

Institutional Trading of Shoulder Innovations

Several institutional investors and hedge funds have recently bought and sold shares of the company. Compass Financial Management LLC acquired a new position in shares of Shoulder Innovations in the 2nd quarter worth approximately $30,000. Wells Fargo & Company MN raised its position in shares of Shoulder Innovations by 66.3% during the 4th quarter. Wells Fargo & Company MN now owns 5,250 shares of the company’s stock valued at $75,000 after acquiring an additional 2,094 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new position in Shoulder Innovations during the third quarter worth $28,000. California State Teachers Retirement System lifted its stake in Shoulder Innovations by 412.4% during the second quarter. California State Teachers Retirement System now owns 2,941 shares of the company’s stock worth $60,000 after purchasing an additional 2,367 shares during the last quarter. Finally, Rhumbline Advisers acquired a new position in Shoulder Innovations in the third quarter worth $54,000.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on the company. Piper Sandler restated an “overweight” rating and set a $25.00 price objective (up from $19.00) on shares of Shoulder Innovations in a research note on Friday, August 7th. BTIG Research upped their target price on Shoulder Innovations from $24.00 to $26.00 and gave the company a “buy” rating in a research report on Friday, August 7th. UBS Group raised their price target on shares of Shoulder Innovations from $27.00 to $28.00 and gave the stock a “buy” rating in a research report on Monday, August 10th. Finally, Weiss Ratings upgraded shares of Shoulder Innovations from a “sell (d-)” rating to a “sell (d)” rating in a research note on Monday, August 3rd. Five research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Shoulder Innovations has an average rating of “Moderate Buy” and a consensus target price of $25.50.

About Shoulder Innovations

Shoulder Innovations (NYSE:SI) is a medical device company focused on the design, development and commercialization of shoulder implant systems and related surgical instruments for orthopedic surgery. The company’s product portfolio includes modular shoulder prostheses, humeral and glenoid components, and instrumentation kits designed to facilitate both primary and revision shoulder arthroplasty procedures. Emphasizing a patient-centric approach, Shoulder Innovations works to offer implant solutions that aim to restore mobility and reduce post-operative complications.

In addition to its core implant offerings, Shoulder Innovations provides comprehensive clinical support and training programs for surgeons and operating room teams.